High PSMA expression was seen in 11 patients (44%); 4/11 leiomyosarcomas, 2/5 dedifferentiated liposarcomas, 3/4 undifferentiated pleomorphic sarcomas, 1/2 myxofibrosarcoma and 1/1 malignant peripheral nerve sheath tumour (MPNST), see Table 2. This evidence concerns the gene FOLH1 and malignant peripheral nerve sheath tumor.